Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology ...Middle East

MENLO PARK, Calif. and CAMBRIDGE, United Kingdom, Dec. 21, 2020 /PRNewswire/ -- Gamma Biosciences, a life sciences tools platform created by KKR, today announced a licensing agreement between Astrea Bioseparations, a leader in affinity chromatography and bioseparations, and Avacta, a...

Hence then, the article about gamma biosciences announces strategic licensing agreement by astrea bioseparations for advanced application of avacta affimer reagent technology was published today ( Monday 21/12/2020 - 10:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology )

Also on site :

• One Minnesota Vikings Rookie Who Could Win a Starting Job Out of Camp
• Paramount Reportedly Considering Leaving California as State Readies Lawsuit Over Warner Bros. Discovery Merger
• Nordstrom Rack’s $27 Pearl Necklace and Bracelet Set Is an ‘Elegant’ Way to Nail the Coastal-Chic Aesthetic